|
Celon Laboratories Limited
Main Activities: Pharmaceutical and Medicine Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Celon Laboratories Limited Headquarters Plot No 2 Aleap Industrial Estate Gajularamaram; Hyderabad; Andhra Pradesh; 500072 |
Status: Non-Listed Legal Form: Limited Liability Company Operational Status: Operational Financial Auditors: P.Murali & Co (2012) Incorporation Date: January 23, 2001 Tel: 91 (40) 40303838 |
|
Company Description |
| Celon Laboratories Limited is a fully integrated Pharmaceutical company a leader in development and marketing of specialty injectable products. Using in-house Research and Development capabilities, together with operational flexibility manufacturing and regulatory expertise, Celon is able to take a wide variety of products from laboratory to the market. ? ? |
Company Analysis |
| According to the Individual - Audited financial statement for the Year of 2011, total net operating revenues increased with 95.76%, from INR 51.93 tens of millions to INR 101.66 tens of millions. Operating result increased from INR 12.56 tens of millions to INR 13.62 tens of millions which means 8.44% change. The results of the period increased 20.90% reaching INR 10.24 tens of millions at the end of the period against INR 8.47 tens of millions last year. Return on equity (Net income/Total equity) went from 50.87% to 12.97%, the Return On Asset (Net income / Total Asset) went from 21.91% to 9.52% and the Net Profit Margin (Net Income/Net Sales) went from 16.31% to 10.07% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 64.08% compared to 220.00% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 2.69 to 5.14 when compared to the previous year. |
Key Executives |
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2011 Y (non-cons) |
2010 Y (non-cons) |
|
 | ||
| Audited | Audited | |
| ||
| EMIS | EMIS | |
| ||
| Unit | Tens of Millions) | Tens of Millions |
| ||
Balance Sheet
| ||
Total Assets |
107 |
38 |
| ||
Current Assets |
XX |
XX |
| ||
Total Liabilities |
XX |
XX |
| ||
Shareholders Equity |
XX |
XX |
| ||
Current Liabilities |
XX |
XX |
| ||
| * All the accounts are in INR. | ||
Income Statement
| ||
Total Operating Revenue |
XXX |
XX |
| ||
Operational Profit (Loss) |
XX |
XX |
| ||
Net Profit (Loss) |
XX |
X |
| ||
| * All the accounts are in INR. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
X.XX% |
XX.XX% |
| ||
Annualised Return on Assets (ROA) |
X.XX% |
XX.XX% |
| ||
Return on Equity (ROE) |
XX.XX% |
XX.XX% |
| ||
Annualised Return on Equity (ROE) |
XX.XX% |
XX.XX% |
| ||
Return on Capital |
X.XX% |
XX.XX% |
| ||
Operating Profit Margin |
XX.XX% |
XX.XX% |
| Efficiency Ratios | ||
| ||
Current asset turnover |
X.XXx |
X.XXx |
| ||
Fixed-asset turnover |
X.XXx |
X.XXx |
| ||
Asset Turnover |
X.XXx |
X.XXx |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
XX |
XX |
| ||
EBITDA |
XX |
XX |
| ||
Bookvalue (BV) |
XX |
XX |
| ||
Net Cash |
- |
X |
| Liquidity Ratios | ||
| ||
Current Ratio |
X.XX% |
X.XX% |
| ||
Quick ratio |
X.XX% |
X.XX% |
| ||
Doom's day ratio |
X.XX% |
X.XX% |
| ||
Cash Flow to Debt |
X% |
-X.XX% |
| Leverage Ratios | ||
| ||
Leverage ratio |
XXX.XX% |
XXX.XX% |
| ||
Interest Coverage Ratio |
X.XX% |
X.X% |
| ||
Debt to equity |
X.XX% |
X.XX% |
| Trend Ratios | ||
| ||
Revenue Trend |
X.XX% |
X.XX% |
| ||
Net Income Trend |
X.XX% |
X.X% |
| ||
Operating Income Trend |
X.XX% |
X.X% |
| Bank Ratios | ||
| ||
Tier 1 Ratio |
XX.XX |
XX.XX |
| ||
 |